Fiona Thistlethwaite
Manchester Academic Health Science Centre(GB)University of Manchester(GB)Cancer Research UK Manchester Institute(GB)The Christie NHS Foundation Trust(GB)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses
Most-Cited Works
- → Involvement of Brca2 in DNA Repair(1998)630 cited
- → Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study(2019)550 cited
- → The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity(2017)403 cited
- → Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study(2019)304 cited
- → Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial(2018)258 cited
- → Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma